These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33117018)

  • 1. Clinical Outcomes of Proton Beam Therapy for Ground-Glass Opacity-Type Lung Cancer.
    Nagata I; Ogino T; Arimura T; Yoshiura T
    Lung Cancer (Auckl); 2020; 11():105-111. PubMed ID: 33117018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer.
    Hatayama Y; Nakamura T; Suzuki M; Azami Y; Ono T; Yabuuchi T; Hayashi Y; Kimura K; Hirose K; Wada H; Hareyama M; Kikuchi Y; Takai Y
    Clin Lung Cancer; 2016 Sep; 17(5):427-432. PubMed ID: 26725851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-Small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan.
    Ohnishi K; Nakamura N; Harada H; Tokumaru S; Wada H; Arimura T; Iwata H; Sato Y; Sekino Y; Tamamura H; Mizoe JE; Ogino T; Ishikawa H; Kikuchi Y; Okimoto T; Murayama S; Akimoto T; Sakurai H
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):82-89. PubMed ID: 31580927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas : Ablative dose PBT for NSCLC.
    Lee SU; Moon SH; Cho KH; Pyo HR; Kim JY; Kim DY; Kim TH; Suh YG; Kim YJ
    Strahlenther Onkol; 2016 Sep; 192(9):649-57. PubMed ID: 27282279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary results of proton-beam therapy for stage III non-small-cell lung cancer.
    Hatayama Y; Nakamura T; Suzuki M; Azami Y; Ono T; Yamaguchi H; Hayashi Y; Tsukiyama I; Hareyama M; Kikuchi Y; Takai Y
    Curr Oncol; 2015 Oct; 22(5):e370-5. PubMed ID: 26628878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Outcomes After Moderate Hypofractionated Proton Therapy for Centrally Located Non-small Cell Lung Cancer.
    Nakamura M; Ishikawa H; Ohnishi K; Baba K; Sumiya T; Murakami M; Hiroshima Y; Mizumoto M; Okumura T; Sakurai H
    Anticancer Res; 2023 May; 43(5):2003-2013. PubMed ID: 37097674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
    Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
    Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.
    Chang JY; Verma V; Li M; Zhang W; Komaki R; Lu C; Allen PK; Liao Z; Welsh J; Lin SH; Gomez D; Jeter M; O'Reilly M; Zhu RX; Zhang X; Li H; Mohan R; Heymach JV; Vaporciyan AA; Hahn S; Cox JD
    JAMA Oncol; 2017 Aug; 3(8):e172032. PubMed ID: 28727865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study investigating hypofractionated proton beam therapy in patients with inoperable early stage non-small cell lung cancer.
    Yang K; Noh JM; Park HY; Yoo H; Shin SH; Pyo H
    Front Oncol; 2024; 14():1296172. PubMed ID: 38444671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of high-dose (74 GyE) proton beam therapy with concurrent chemotherapy for stage III nonsmall-cell lung cancer.
    Ohnishi K; Ishikawa H; Nakazawa K; Shiozawa T; Mori Y; Nakamura M; Okumura T; Sekine I; Hizawa N; Sakurai H
    Thorac Cancer; 2021 May; 12(9):1320-1327. PubMed ID: 33675285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and prognosis of clinical N0 non-small cell lung cancer exceeding 30 mm.
    Kagimoto A; Tsutani Y; Handa Y; Mimae T; Miyata Y; Okada M
    Jpn J Clin Oncol; 2020 Oct; 50(11):1306-1312. PubMed ID: 32901276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proton beam therapy with concurrent chemotherapy for non-small cell lung cancer -- our experiences and future direction].
    Niho S; Motegi A; Akimoto T
    Gan To Kagaku Ryoho; 2015 Feb; 42(2):144-7. PubMed ID: 25743132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical results of proton beam therapy in patients with idiopathic pulmonary fibrosis: a single center experience.
    Ono T; Hareyama M; Nakamura T; Kimura K; Hayashi Y; Azami Y; Hirose K; Hatayama Y; Suzuki M; Wada H; Kikuchi Y; Nemoto K
    Radiat Oncol; 2016 Apr; 11():56. PubMed ID: 27090216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Risk Non-Small Cell Lung Cancer Treated With Active Scanning Proton Beam Radiation Therapy and Immunotherapy.
    Carrasquilla M; Paudel N; Collins BT; Anderson E; Krochmal R; Margolis M; Balawi A; DeBlois D; Giaccone G; Kim C; Liu S; Lischalk JW
    Adv Radiat Oncol; 2023; 8(2):101125. PubMed ID: 36578277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity.
    Sagawa M; Oizumi H; Suzuki H; Uramoto H; Usuda K; Sakurada A; Chida M; Shiono S; Abe J; Hasumi T; Sato M; Sato N; Shibuya J; Deguchi H; Okada Y
    Eur J Cardiothorac Surg; 2018 Apr; 53(4):849-856. PubMed ID: 29236995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes After Proton Beam Therapy for Locally Advanced Non-Small Cell Lung Cancer: Analysis of a Multi-institutional Prospective Registry.
    Jongen A; Charlier F; Baker K; Chang J; Hartsell W; Laramore G; Mohindra P; Moretti L; Redman M; Rosen L; Tsai H; Van Gestel D; Vargas C; Rengan R
    Adv Radiat Oncol; 2022; 7(1):100767. PubMed ID: 35071826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of proton beam therapy without concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer.
    Oshiro Y; Mizumoto M; Okumura T; Hashimoto T; Fukumitsu N; Ohkawa A; Kanemoto A; Hashii H; Ohno T; Sakae T; Tsuboi K; Sakurai H
    J Thorac Oncol; 2012 Feb; 7(2):370-5. PubMed ID: 22157368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results after surgical treatment of the dominant lung adenocarcinoma associated with ground-glass opacities.
    Bongiolatti S; Corzani R; Borgianni S; Meniconi F; Cipollini F; Gonfiotti A; Viggiano D; Paladini P; Voltolini L
    J Thorac Dis; 2018 Aug; 10(8):4838-4848. PubMed ID: 30233857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublobar resections for small-sized stage Ia lung adenocarcinoma: a Sino-Japanese multicenter study.
    Zhong C; Sakurai H; Wei S; Fang W; Asamura H
    J Thorac Dis; 2018 Feb; 10(2):991-998. PubMed ID: 29607172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
    Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
    Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.